The manufacturer of protective costumes from Ebola filed a lawsuit for $ 500 million

The American neurosurgeon Church of Shahinyan filed a lawsuit for $ 500 million in the Federal Court of Los Angeles to the Kimberly-Clack Corporation for misinformation of customers about the protective properties of his products. It is reported by Bloomberg. Shahinyan claims that the company set economic interest above public security, saying that the special -coins of its production are protected from Ebola’s fever, initially knowing that this is not so. The complaint states that the tests of products conducted in 2013 showed that the robes, declared as impenetrable, pass liquid pathogens through the tissue, which, in turn, endanates the health of health workers and patients. In the lawsuit, Shahinyan claims that in 2013, Kimberly-Claark knew about the results of industrial tests, but they did not stop the sale of special huts.

“The recklessness and irresponsibility of the Kimberly-Claark is jealous of infection of both patients and medical staff and can lead to inevitable consequences. All this is completely unacceptable, ”the complaint says.

Shainyan requires a payment of $ 500 million from the company for using this costume, he potentially at risk of infection with fever. The collective claim for fraud was filed on behalf of all customers who used protective costumes. In turn, the representative of Kimberly-Claark Bob Brand refused to comment, emphasizing that "the company is responsible for the safety and efficiency of its products." American Corporation Kimberly-Clark Corp. He is engaged in the production of healthcare products, personal, professional and industrial hygiene under the brands of Huggies, Kleenex, Kotex and a number of others.

The outbreak of the Ebola virus was recorded in Guinea in December 2013. According to WHO, almost five thousand people died from the epidemic, most deaths are in Africa countries-Liberia, Sierra Leone and Guinea. Cases of infection with the virus were also identified in Western countries - the USA and Spain. An effective vaccine against Ebola has not yet been developed.